Ophthalmic Business Council
For more than 25 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.
OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.
To join or learn more, contact Todd Lyckberg at 415.447.0361 or email@example.com.
Download brochures: AAO 2021-22 exhibitors and non-exhibitors
Save the Date
Spring 2021 Symposium
April 9, 2021
Virtual Meeting - 1:00 p.m. (EDT) / 10:00 a.m. (PDT)
Held every other year, the Spring Symposium focuses on the latest first-hand from experts on FDA, Medicare and reimbursement issues. As the speed of innovation grows, this event helps you navigate the complexities of introducing new technologies and treatments to patients. Unlike the Fall Symposium, Academy leaders do not attend this meeting.
Fall 2021 Symposium
Sept. 9-10, 2021
San Francisco, Calif.
Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.
2020 - 2021 Ophthalmic Business Council
Platinum Benefactors ($35,000)
Crown Benefactors ($25,000)
Allergan, an AbbVie Company
Regeneron Pharmaceuticals, Inc.
Bausch + Lomb
Johnson & Johnson Vision
Aerie Pharmaceuticals, Inc.
Carl Zeiss Meditec, Inc.
Leadiant Biosciences, Inc.
Spark Therapeutics, Inc.
Sight Sciences, Inc.
W. L. Gore & Associates